BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 27778203)

  • 1. Tissue Transglutaminase Levels Are Not Sufficient to Diagnose Celiac Disease in North American Practices Without Intestinal Biopsies.
    Elitsur Y; Sigman T; Watkins R; Porto AF; Leonard Puppa EL; Foglio EJ; Preston DL
    Dig Dis Sci; 2017 Jan; 62(1):175-179. PubMed ID: 27778203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice.
    Werkstetter KJ; Korponay-Szabó IR; Popp A; Villanacci V; Salemme M; Heilig G; Lillevang ST; Mearin ML; Ribes-Koninckx C; Thomas A; Troncone R; Filipiak B; Mäki M; Gyimesi J; Najafi M; Dolinšek J; Dydensborg Sander S; Auricchio R; Papadopoulou A; Vécsei A; Szitanyi P; Donat E; Nenna R; Alliet P; Penagini F; Garnier-Lengliné H; Castillejo G; Kurppa K; Shamir R; Hauer AC; Smets F; Corujeira S; van Winckel M; Buderus S; Chong S; Husby S; Koletzko S;
    Gastroenterology; 2017 Oct; 153(4):924-935. PubMed ID: 28624578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy.
    Wolf J; Petroff D; Richter T; Auth MKH; Uhlig HH; Laass MW; Lauenstein P; Krahl A; Händel N; de Laffolie J; Hauer AC; Kehler T; Flemming G; Schmidt F; Rodrigues A; Hasenclever D; Mothes T
    Gastroenterology; 2017 Aug; 153(2):410-419.e17. PubMed ID: 28461188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
    Husby S; Murray JA; Katzka DA
    Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of anti-transglutaminase antibodies in the diagnosis of celiac disease].
    Fernández ML; Vivas S; Ruiz de Morales JM; Marugán JM
    Gastroenterol Hepatol; 2005 Oct; 28(8):437-40. PubMed ID: 16185576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of Anti-Tissue Transglutaminase IgA Antibody in the Diagnosis of Paediatric Celiac Disease.
    Hashmi MA; Hussain T; Masood N; Younas M; Asghar RM; Shafi MS
    J Coll Physicians Surg Pak; 2016 Apr; 26(4):263-6. PubMed ID: 27097694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay.
    Mankaï A; Sakly W; Landolsi H; Gueddah L; Sriha B; Ayadi A; Sfar MT; Skandrani K; Harbi A; Essoussi AS; Korbi S; Fabien N; Jeddi M; Ghedira I
    Pathol Biol (Paris); 2005 May; 53(4):204-9. PubMed ID: 15850953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population.
    Gidrewicz D; Potter K; Trevenen CL; Lyon M; Butzner JD
    Am J Gastroenterol; 2015 May; 110(5):760-7. PubMed ID: 25823767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease.
    Caruso R; Marafini I; Del Vecchio Blanco G; Fina D; Paoluzi OA; Colantoni A; Sedda S; Pallone F; Monteleone G
    Dig Liver Dis; 2014 Apr; 46(4):323-9. PubMed ID: 24394601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histopathological correlation of duodenal biopsy with IgA anti-tissue transglutaminase titers in children with celiac disease.
    Bhattacharya M; Lomash A; Sakhuja P; Dubey AP; Kapoor S
    Indian J Gastroenterol; 2014 Jul; 33(4):350-4. PubMed ID: 24859392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of IgA tTG in Predicting Mucosal Recovery in Children With Celiac Disease on a Gluten-Free Diet.
    Leonard MM; Weir DC; DeGroote M; Mitchell PD; Singh P; Silvester JA; Leichtner AM; Fasano A
    J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):286-291. PubMed ID: 28112686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease.
    Zanini B; Magni A; Caselani F; Lanzarotto F; Carabellese N; Villanacci V; Ricci C; Lanzini A
    Dig Liver Dis; 2012 Apr; 44(4):280-5. PubMed ID: 22119616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celiac disease can be predicted by high levels of anti-tissue transglutaminase antibodies in population-based screening.
    Webb C; Norström F; Myléus A; Ivarsson A; Halvarsson B; Högberg L; Lagerqvist C; Rosén A; Sandström O; Stenhammar L; Carlsson A
    J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):787-91. PubMed ID: 25564816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue transglutaminase levels above 100 U/mL and celiac disease: a prospective study.
    Mubarak A; Wolters VM; Gmelig-Meyling FH; Ten Kate FJ; Houwen RH
    World J Gastroenterol; 2012 Aug; 18(32):4399-403. PubMed ID: 22969205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of small-bowel mucosal transglutaminase-2 specific autoantibody deposits in the diagnosis and follow-up of celiac disease.
    Koskinen O; Collin P; Lindfors K; Laurila K; Mäki M; Kaukinen K
    J Clin Gastroenterol; 2010 Aug; 44(7):483-8. PubMed ID: 19779364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are ESPGHAN "biopsy-sparing" guidelines for celiac disease also suitable for asymptomatic patients?
    Trovato CM; Montuori M; Anania C; Barbato M; Vestri AR; Guida S; Oliva S; Mainiero F; Cucchiara S; Valitutti F
    Am J Gastroenterol; 2015 Oct; 110(10):1485-9. PubMed ID: 26372508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-titre circulating tissue transglutaminase-2 antibodies predict small bowel villous atrophy, but decision cut-off limits must be locally validated.
    Beltran L; Koenig M; Egner W; Howard M; Butt A; Austin MR; Patel D; Sanderson RR; Goubet S; Saleh F; Lavender J; Stainer E; Tarzi MD
    Clin Exp Immunol; 2014 May; 176(2):190-8. PubMed ID: 24325651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Screening for Celiac Disease, Deamidated Gliadin Rarely Predicts Disease When Tissue Transglutaminase Is Normal.
    Gould MJ; Brill H; Marcon MA; Munn NJ; Walsh CM
    J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):20-25. PubMed ID: 30052564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue transglutaminase antibody determination in celiac disease. Analysis of diagnostic specificity of anti-human IgA-type assays.
    Földes-Papp Z; Demel U; Berry D; Domej W; Fuchs D; Tilz GP
    J Immunoassay Immunochem; 2002; 23(2):211-27. PubMed ID: 12033644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum intestinal fatty acid-binding protein in the noninvasive diagnosis of celiac disease.
    Oldenburger IB; Wolters VM; Kardol-Hoefnagel T; Houwen RHJ; Otten HG
    APMIS; 2018 Mar; 126(3):186-190. PubMed ID: 29383769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.